Touching Base

By Genetic Engineering & Biotechnology News (GEN)

Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.


Category: Life Sciences

Open in Apple Podcasts


Open RSS feed


Open Website


Rate for this podcast

Subscribers: 0
Reviews: 0
Episodes: 19

Description

Touching Base is the dynamic new podcast series from the Editors of GEN (Genetic Engineering & Biotechnology News). Each week, Senior Editors Kevin Davies, Julianna LeMieux, Alex Philippidis, Jonathan Grinstein, Uduak Thomas, and Fay Lin delve into emerging stories, exchange ideas, and debate the latest trends in biotech plus talk to some of the leading voices in the industry about what's now and next. Start listening today!

Hosted on Acast. See acast.com/privacy for more information.


Episode Date
DNA Day: Deep Dive
Apr 26, 2024
How Biotechs Are Plugging AI into Drug Discovery Problems
Apr 19, 2024
Launch of Nvelop Therapeutics for Delivery of Genetic Cargo, AACR Recap
Apr 12, 2024
Dried Blood COVID Dx, Cryo-Shocked Tumor Cell Delivery Vehicles, Verve Halts Trial, Iambic Starts Trial, and Diagonal Therapeutics Launches
Apr 05, 2024
AI in Drug Discovery and Precision Medicine: Nvidia GTC and Precision Med TRI-CON
Mar 29, 2024
Optimizing Nanoparticles and Messenger RNAs with Multiple “Tails”
Mar 22, 2024
NanoString Finds a Buyer, Slide Tags Enter in Early Access as Curio Trekker, Cellares Unveils Cell Therapy Manufacturing Platform
Mar 15, 2024
International Women’s Day, Nanoparticles and Delivery, Novo Nordisk’s Expansion, and Organoids for Congenital Conditions
Mar 08, 2024
Moderna Gets Back to Its Roots, Form Bio and Ginkgo Bioworks Team Up, and Under-the-Radar Rare Autoimmune Diseases
Mar 01, 2024
Prime Editing for Isogenic iPSCs, PRINT, Universal In Vivo CAR T Editing, Biogen Q4 Results Disappoint; Andrea Choe
Feb 23, 2024
CRISPRed Pigs, Exscientia Fires CEO, & AGBT Roundup; Christian Henry
Feb 16, 2024
Intellia and Ultragenyx’s Clinical Updates, Novo Holdings’ Catalent Acquisition, and NanoString Bankruptcy; Simon Barnett
Feb 09, 2024
Genome Interpretation, Nanoparticles, Gene Therapy, 2024 IPOs; Nautilus Biotechnology
Feb 02, 2024
Restoring Hearing Loss, CAR T Manufacturing, DNA-Based Medicines, Nvidia and Recursion; Eric Topol
Jan 26, 2024
Alzheimer’s Disease, Monkey Cloning, Cytokinetics Stock; Jen Nwankwo
Jan 18, 2024
J.P. Morgan 2024: Illumina, 10x, Danaher, AI; Liberate Bio
Jan 11, 2024
Novartis and Voyager, JPM Ahead, Epigenetic Engineering; Alex Aravanis
Jan 05, 2024
Launch of Tome Biosciences, AI scientist, mRNA vaccines
Dec 21, 2023
Autism, AI and Epigenetics; Nevan Krogan
Dec 08, 2023